Somatic mutation of EGFR catalytic domain and treatment with gefitinib in colorectal cancer.
Moroni
M
M
Sartore-Bianchi
A
A
Benvenuti
S
S
Artale
S
S
Bardelli
A
A
Siena
S
S
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000235:genetics* / Q000556:secondary; D066246:ErbB Receptors / Q000037:antagonists & inhibitors / Q000235:genetics*; D000077156:Gefitinib; D006801:Humans; D009154:Mutation / Q000187:drug effects* / Q000235:genetics*; D011799:Quinazolines / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D011799:Quinazolines; D066246:ErbB Receptors; D000077156:Gefitinib